White Matter Damage in the Cholinergic System Contributes to Cognitive Impairment in Subcortical Vascular Cognitive Impairment, No Dementia
暂无分享,去创建一个
Stefan J. Teipel | Jianwei Yang | Zude Zhu | S. Teipel | Zude Zhu | J. Jia | Yi Tang | Yi Tang | Qing Liu | Yi Xing | Jianping Jia | Y. Xing | Jianwei Yang | Qing Liu | Yi Tang
[1] M. Mesulam,et al. Cholinergic denervation in a pure multi-infarct state , 2003, Neurology.
[2] H. Vankova. Mini Mental State , 2010 .
[3] C. Geula,et al. Nucleus basalis (Ch4) and cortical cholinergic innervation in the human brain: Observations based on the distribution of acetylcholinesterase and choline acetyltransferase , 1988, The Journal of comparative neurology.
[4] Keith A. Johnson,et al. The Evolution of Preclinical Alzheimer’s Disease: Implications for Prevention Trials , 2014, Neuron.
[5] C. Jack,et al. Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment , 2004, Journal of internal medicine.
[6] Daniel Rueckert,et al. Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data , 2006, NeuroImage.
[7] H. Tohgi,et al. Cerebrospinal fluid acetylcholine and choline in vascular dementia of Binswanger and multiple small infarct types as compared with Alzheimer-type dementia , 2005, Journal of Neural Transmission.
[8] D. Streiner,et al. Strategic subcortical hyperintensities in cholinergic pathways and executive function decline in treated Alzheimer patients. , 2007, Archives of neurology.
[9] H. Heinsen,et al. Atrophy of the Cholinergic Basal Forebrain Over the Adult Age Range and in Early Stages of Alzheimer's Disease , 2012, Biological Psychiatry.
[10] C. P. Hughes,et al. A New Clinical Scale for the Staging of Dementia , 1982, British Journal of Psychiatry.
[11] C. Beaulieu,et al. The basis of anisotropic water diffusion in the nervous system – a technical review , 2002, NMR in biomedicine.
[12] Seol-Heui Han,et al. The Effect of Ischemic Cholinergic Damage on Cognition in Patients With Subcortical Vascular Cognitive Impairment , 2012, Journal of geriatric psychiatry and neurology.
[13] M. Ihara,et al. Loss of Cholinergic Pathways in Vascular Dementia of the Binswanger Type , 2005, Dementia and Geriatric Cognitive Disorders.
[14] O Salonen,et al. Cognitive profile of subcortical ischaemic vascular disease , 2005, Journal of Neurology, Neurosurgery & Psychiatry.
[15] S. Salloway,et al. Efficacy and Tolerability of Donepezil in Vascular Dementia: Positive Results of a 24-Week, Multicenter, International, Randomized, Placebo-Controlled Clinical Trial , 2003, Stroke.
[16] Stefan Klöppel,et al. Subregional basal forebrain atrophy in Alzheimer's disease: a multicenter study. , 2014, Journal of Alzheimer's disease : JAD.
[17] Serge Gauthier,et al. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial , 2002, The Lancet.
[18] Sandra E Black,et al. Strategic involvement of cholinergic pathways and executive dysfunction: Does location of white matter signal hyperintensities matter? , 2003, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[19] G. Frisoni,et al. Fractional anisotropy changes in Alzheimer's disease depend on the underlying fiber tract architecture: a multiparametric DTI study using joint independent component analysis. , 2014, Journal of Alzheimer's disease : JAD.
[20] Harald Hampel,et al. The cholinergic system in mild cognitive impairment and Alzheimer's disease: An in vivo MRI and DTI study , 2011, Human brain mapping.
[21] R. Doody,et al. Donepezil in vascular dementia , 2003, Neurology.
[22] Won-Jin Moon,et al. Differential cholinergic pathway involvement in Alzheimer's disease and subcortical ischemic vascular dementia. , 2013, Journal of Alzheimer's disease : JAD.
[23] Suiping Wang,et al. Separate Brain Circuits Support Integrative and Semantic Priming in the Human Language System. , 2015, Cerebral cortex.
[24] M. Mesulam,et al. Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain. , 1998, Brain : a journal of neurology.
[25] H. Hanyu,et al. MR features of the substantia innominata and therapeutic implications in dementias , 2007, Neurobiology of Aging.
[26] R. Kalaria,et al. Cholinergic Neuronal Deficits in CADASIL , 2007, Stroke.
[27] K. Blennow,et al. Decreased Cerebrospinal Fluid Acetylcholinesterase in Patients with Subcortical Ischemic Vascular Dementia , 2003, Dementia and Geriatric Cognitive Disorders.
[28] Timothy A. Salthouse,et al. Speed Mediation of Adult Age Differences in Cognition , 2005 .
[29] D. Salmon,et al. The prevalence of dementia and Alzheimer's disease in Shanghai, China: Impact of age, gender, and education , 1990, Annals of neurology.
[30] K. Jellinger,et al. Post-mortem assessment in vascular dementia: advances and aspirations , 2016, BMC Medicine.
[31] P. Scheltens,et al. Atrophy of medial temporal lobes on MRI in “probable” Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates , 2012, Journal of Neurology, Neurosurgery & Psychiatry.
[32] K. Nagata,et al. [Alzheimer's disease and vascular dementia]. , 2014, Nihon rinsho. Japanese journal of clinical medicine.
[33] Piero Antuono,et al. Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors , 2008, The Lancet Neurology.
[34] P. Scheltens,et al. Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[35] K. Amunts,et al. Reduction of basal forebrain cholinergic system parallels cognitive impairment in patients at high risk of developing Alzheimer's disease. , 2010, Cerebral cortex.
[36] Richard J. Kryscio,et al. White matter integrity is associated with cerebrospinal fluid markers of Alzheimer's disease in normal adults , 2014, Neurobiology of Aging.
[37] Agnieszka Z. Burzynska,et al. Diffusion tensor imaging of cerebral white matter integrity in cognitive aging. , 2012, Biochimica et biophysica acta.
[38] M. Mesulam. Cholinergic Aspects of Aging and Alzheimer's Disease , 2012, Biological Psychiatry.
[39] H. Chui,et al. Preservation of neurons of the nucleus basalis in subcortical ischemic vascular disease. , 2012, Archives of neurology.
[40] A. Alavi,et al. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. , 1987, AJR. American journal of roentgenology.
[41] H. Möller,et al. Measurement of basal forebrain atrophy in Alzheimer's disease using MRI. , 2005, Brain : a journal of neurology.
[42] S. Jang,et al. Neural pathway from nucleus basalis of Meynert passing through the cingulum in the human brain , 2010, Brain Research.
[43] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[44] D. A. Kenny,et al. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. , 1986, Journal of personality and social psychology.
[45] P. Basser,et al. A model for diffusion in white matter in the brain. , 2005, Biophysical journal.